The influence of active hexose correlated compound (AHCC) on cisplatin-evoked chemotherapeutic and side effects in tumor-bearing mice

Cisplatin and platinum drugs at the molecular level (Review)

Teni Boulikas, Maria Vougiouka · Oncology Reports · 2003 · 728 citations

Medicine, Oncology, Pharmacology +14

Prognostic factors for survival in advanced non-small-cell lung cancer: univariate and multivariate analyses including recursive partitioning and amalgamation algorithms in 1,052 patients. The European Lung Cancer Working Party.

Marianne Paesmans, Jean‐Paul Sculier, P Libert et al. · Journal of Clinical Oncology · 1995 · 394 citations

Medicine, Biostatistics, Oncology +17

p38 MAP kinase inhibition ameliorates cisplatin nephrotoxicity in mice

Ganesan Ramesh, William Reeves · American Journal of Physiology-Renal Physiology · 2005 · 263 citations

Medicine, Oncology, Pharmacology +17

Supplementation with antioxidant micronutrients and chemotherapy-induced toxicity in cancer patients treated with cisplatin-based chemotherapy: a randomised, double-blind, placebo-controlled study

Nir I. Weijl, T.J Elsendoorn, Eef G.W.M. Lentjes et al. · European Journal of Cancer · 2004 · 254 citations

Medicine, Oncology, Pharmacology +17

Cisplatin-induced cell death is EGFR/<i>src</i>/ERK signaling dependent in mouse proximal tubule cells

István Arany, Judit Megyesi, Hideaki Kaneto et al. · American Journal of Physiology-Renal Physiology · 2004 · 212 citations

Life Sciences, Cell Biology, Oncology +17